Day 1 - Wednesday, 7 October 2020

Meeting category
Date(s)
7 Oct 2020 - 8 Oct 2020
Organizer

Platinum Level Support
Sponsor logos

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2020
Related Enduring Materials
Enduring Materials
Opening session - 10:00
10:00 EDT
Opening words

Grace Aldrovandi, MD, CM
University of California, Los Angeles, USA

Ronald Collman, MD
University of Pennsylvania's Perelman School of Medicine, USA

Alan Landay, PhD
Rush University Medical Center, USA
10:05 EDT
Keynote: Capturing the Dynamics of Phage-bacteria Interactions in the Respiratory Tract Using Metagenomics and Metatranscriptomics
Session 1: Transmission -
Chair

Catherine Lozupone
University of Colorado Anschutz Medical Campus

Sergio Serrano-Villar, MD, PhD
University Hospital Ramón y Cajal, Madrid, Spain
10:45 EDT
The Impact of Hormonal Contraception on the Vaginal Microbiome and HIV Acquisition
11:05 EDT
Understanding the Rectal Mucosal Immune Environment and Potential Impacts on HIV Transmission
11:25 EDT
The Microbiome and SIV Acquisition
Session 2: Pathogenesis -
Chairs

Nichole Klatt, PhD
University of Washington, USA

Jason Brenchley, MA, PhD
National Institutes of Health, USA
12:10 EDT
Intestinal microbial communities and the intestinal microbe Holdemanella biformis isolated from HIV+/- men who have sex with men increase CCR5 expression on intestinal CD4 T cells
Eiko Yamada
#O_01
12:17 EDT
Fecal Proteobacteria Positively Correlates with The Activation of Circulating ISGs and CD4+ T Cells in Vesatolimod-treated HIV Controllers on ART
Yanhui Cai
#O_02
12:24 EDT
Alterations in the Gut Microbiome of HIV infected patients under Antiretroviral Therapy
Shilpa Ray
#O_03
12:31 EDT
Changes in Gut Microbiome in HIV-Infected Individuals Undergoing Long Term Antiretroviral Therapy Receiving Rifaximin: Results of the GUTCHEK Study
James Virga
#O_04
12:45 EDT
Poster viewing 1 (#P_01-P_07)
DAY 2 - Thursday, 8 October
- 10:00
10:00 EDT
Opening words

Chairs: Ronald Collman, MD
University of Pennsylvania's Perelman School of Medicine, USA

Chairs: Alan Landay, PhD
Rush University Medical Center, USA
10:00 EDT
Keynote: Probing the Microbiome in Disease: From CRC to HIV
Session 3: Prevention -
Chairs

Gilda Tachedjian, BSc (Hons), PhD
Burnet Institute, Melbourne, Australia

Jim Turpin
NIH, USA
10:40 EDT
Connecting the Dots: Translating the Vaginal Microbiome into a Drug
11:00 EDT
Impact of Penile Microbiome on Local Immunology and HIV Susceptibility
11:20 EDT
HIV Replication, Transmission, and the Metabolome of the Female Reproductive Tract
Kaitlin Marquis
#O_05
11:27 EDT
Lactic acid produced by an optimal vaginal microbiota promotes cervicovaginal epithelial barrier integrity: implications for HIV transmission
Brianna Jesaveluk
#O_06
11:50 EDT
Poster viewing 2 (#P_01-P_07)
Session 4: Comorbidities -
Chairs

Roger Paredes, MD, PhD
IrsiCaixa AIDS Research Institute, Badalona, Catalonia, Spain

Laurel Lagenaur, PhD
NIH, USA
12:20 EDT
Intestinal Cytotoxic CD4+ T Cells are Linked to Immune Activation and Dysbiosis in Untreated HIV infection
12:40 EDT
Microbiome and Cardiometabolic risk in HIV and non-HIV Populations
Session 5: Vaccines & Therapeutics -
Chairs

Frederic Bushman
University of Pennsylvania, USA

Satya Dandekar, PhD
University of California, Davis, USA
13:25 EDT
The Microbiome in HIV Vaccines
13:45 EDT
The Impact of the Microbiome on Immunity to Vaccination in Humans
14:05 EDT
Baseline gut-associated microbial signatures may help predict HIV-1 viral control after treatment interruption
Alessandra Borgognone
O_#07
14:12 EDT
Gut microbial regulation of anxiety disorder in a murine model of HIV-1 and opioid abuse
Shamsudheen Moidunny
#O_08
Closing remarks - 14:30
14:30 EDT
Closing remarks

Grace Aldrovandi, MD, CM
University of California, Los Angeles, USA

Ronald Collman, MD
University of Pennsylvania's Perelman School of Medicine, USA

Alan Landay, PhD
Rush University Medical Center, USA
Overview
Committees
Support
Endorsers